论文信息 - Ribociclib (RIB) + fulvestrant (FUL) in postmenopausal women with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC): Results from MONALEESA-3 - 字舞流文

Ribociclib (RIB) + fulvestrant (FUL) in postmenopausal women with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC): Results from MONALEESA-3

P. Neven | X. Pivot | G. Jerusalem | M. Martín | K. Petráková | T. Taran | D. Slamon | G. Vidam | P. Fasching | Y. Wang | K. Rodriguez Lorenc | M. Miller | F. Esteva | S. Im | S. Chia | M. de Laurentiis | GV Bianchi